首页 正文

Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation

{{output}}
Asthma is a deadly chronic respiratory disease affecting over 300 million people. While allergen immunotherapy remains the only disease-modifying treatment, it is poorly applicable for patients with severe asthma. Here, we explored the therapeutic potential of... ...